Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

T cell’s memory may offer long-term immunity to leishmaniasis

08.10.2004


Researchers at the University of Pennsylvania have discovered a "central memory" form of "helper" T cells that can offer immunity to leishmaniasis, a disease that causes considerable death and disfigurement across the globe and has been found in U.S. military personnel returning from Afghanistan and Iraq.



In the October issue of Nature Medicine, the Penn researchers describe how the discovery can offer immunity to leishmaniasis, even without the persistent presence of the parasite that caused the disease. Their findings encourage a new approach to creating a vaccine against leishmaniasis and other immune cell mediated diseases such as tuberculosis and HIV/AIDS.

Attempts to create a vaccine for leishmaniasis have long been stymied by the fact that the helper T cells, which coordinate the immune response against a pathogen, need constant stimulation from the pathogen in order to remain effective against the disease. "Without the persistent attack from the Leishmania parasite, the immune system does not keep protective CD4+ T cells in place," said Phillip Scott, professor and chair of the Department of Pathobiology at Penn’s School of Veterinary Medicine. "The strategy of most vaccines, to ’teach’ the immune system to remember a pathogen, just doesn work with leishmaniasis.


"We have found that a new form of long-term memory T cell will, if stimulated, turn into the sort of helper T cells that mediate the immune response. We believe that, if we can stimulate the expansion of these central memory T cells, we ought to be able to create an effective vaccine."

Leishmaniasis is a parasitic disease spread by the bite of sand flies infected with the protozoan Leishmania. While the disease is most common in North Africa, the Middle East and Asia, it has been recently been seen in United States military personnel who have served in Afghanistan and Iraq.

According to the Centers for Disease Control, each year the world sees 1.5 million new cases of cutaneous leishmaniasis, which infects the skin, causing scarring boils, and 500,000 new cases of visceral leishmaniasis, which infects internal organs, causing death if left untreated.

Particularly vexing to researchers has been the fact that while people who recover from leishmaniasis generally develop lifelong immunity to reinfection, this has been thought to depend upon the continued presence of the Leishmania parasite. Indeed, it has been shown in mice that if the parasite is entirely removed, the host can become reinfected with disease.

Scott and his colleagues wondered if, despite the apparent loss of immunity when the parasites disappeared, there were any T cells that still retained memory of Leishmania. Recent studies have shown that memory T cells may be of more than one type. One type, which is less activated and found in the lymph nodes, is called central memory T cells. Since little is known about CD4+ T cell memory during chronic disease, the Penn researchers set out to find if such central memory cells exist in leishmaniasis.

The hunt for the theoretical CD4+ central memory T cells began by transferring T cells from mice infected with leishmaniasis to mice who had never faced the disease. According to Scott, some of the transferred T cells went to the lymph nodes, and had the characteristics of central memory cells.

"We see that these central memory T cells but not the effector T cells persist in the absence of obvious parasites for as long as five months," Scott said. "Since we still do not know much about these new T cells, our next step is to find out how we can encourage the proliferation of central memory cells and stimulate them to fight disease."

According to Scott, a better understanding of central memory T cells may lead to the development of vaccines that fight off a range of pathogens that respond well to a helper T cell response.

Funding for this research was provided through grants from the National Institutes of Health

Greg Lester | EurekAlert!
Further information:
http://www.upenn.edu

More articles from Life Sciences:

nachricht Bolstering fat cells offers potential new leukemia treatment
17.10.2017 | McMaster University

nachricht Ocean atmosphere rife with microbes
17.10.2017 | King Abdullah University of Science & Technology (KAUST)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Ocean atmosphere rife with microbes

17.10.2017 | Life Sciences

Neutrons observe vitamin B6-dependent enzyme activity useful for drug development

17.10.2017 | Life Sciences

NASA finds newly formed tropical storm lan over open waters

17.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>